English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

A novel approach for the synthesis of unsymmetrically substituted dibenzo[ b,f ][1,5]diazocine-6,12(5 H ,11 H )diones has been developed. This facile three-step method uses variously substituted 1 H -benzo[ d ][1,3]oxazine-2,4-diones (isatoic anhydrides) and 2-aminobenzoic acids as a starting materials. The obtained products were further transformed into N -alkyl-, N -acetyl- and dithio analogues. Developed procedures allowed the synthesis of unsymmetrical dibenzo[ b,f ][1,5]diazocine-6,12(5 H ,11 H )diones and three novel heterocyclic scaffolds: benzo[ b ]naphtho[2,3- f ][1,5]diazocine-6,14(5 H ,13 H )dione, pyrido[3,2- c ][1,5]benzodiazocine-5,11(6 H ,12 H )-dione and pyrazino[3,2- c ][1,5]benzodiazocine-6,12(5 H ,11 H )dione. For 11 of the compounds crystal structures were obtained. The preliminary cytotoxic effect against two cancer (HeLa, U87) and two normal lines (HEK293, EUFA30) as well as antibacterial activity were determined. The obtained dibenzo[ b,f ][1,5]diazocine(5 H ,11 H )6,12-dione framework could serve as a privileged structure for the drug design and development.

Unsymmetrically Substituted Dibenzo[b,f][1,5]-diazocine-6,12(5H,11H)dione—A Convenient Scaffold for Bioactive Molecule Design